1Koenuma M,Kasai H,Uchida N,et al.Pharmacokinetic correlation between experimental and clinical effects on human non-small cell lung cancers of cis-diammineglycolatoplatinum (254-S) and cis-diamminedichloroplatinum.Anticancer Res,1995,15(2):417-421.
2Micheletti E,laFace B,Bianchi E,et al.Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri ⅡB-ⅢB(UICC):a phase Ⅰ/Ⅱ and pharmacokinetic study.Am J Clin Oncol,1997,20(6):613-620.
3Desoize B,Madoulet C.Particular aspects of platinum compounds used at present in cancer treatment.Crit Rev Oncol Hematol,2002,42(3):317-325.
4Furuse K,Fukuoka M,Asamoto H,et al.A randomized comparative study of 254-S plus vindesine (VDS) vs cisplatin (CDDP) plus VDS in patients with advanced non-small cell lung cancer (NSCLC).Gan To Kagaku Ryoho,1992,19(7):1019-1026.
1Taguchi T, Wakui A, Nabeya K, et al. A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group [J]. Gan To Kagaku Ryoho, 1992,19(4):483-488.
2Inuyama Y, Miyake H, Horiuchi M, et al. A late phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck cancers [J]. Gan To Kagaku Ryoho, 1992,19(6): 871-877.
3Le Chevalier T, Brisgand D, Douillard JY, et al. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients[J]. J Clin Oncol, 1994,12:360-367.
4Furuse K, Fukuoka M, Asamoto H, et al. A randomized comparative study of 254-S plus vindesine(VDS) vs. cisplatin (CDDP) plus VDS in patients with advanced non-small cell lung cancer (NSCLC) [J]. Gan To Kagaku Ryoho,1992,19(7):1019-1026.
5Fukuda M, Shinkai T, Eguchi K, et al. Phase II study of (glycolate-O,O′ ) diammineplatinum(II), a novel platinum complex, in the treatment of non-small-cell lung cancer [J]. Cancer Chemother Pharmacol,1990,26(6):393-396.
6Yoshioka T, Gamoh M, Shineha R, et al. A new combination chemotherapy with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for advanced esophageal cancers [J]. Intern Med, 1999, 38(11): 844-848.
5Spensley S, Hunter RD, Livsey JE, et al. Clinical outcome for chernor- adiotherapy in carcinoma of the cervix [ J ]. Clinical oncology, 2009,1 (1) :49 -55.
6Nedovic J, Protrka Z, Ninkovic S, et al. Cisplatin monotherapy with concurrent radiotherapy versus combination of cisplatin and 5 - flu- orouracil chemotherapy with concurrent radiotherapy in patients with locoregionally advanced cervical carcinoma [ J ]. J BUON, 2012, 17 (4) :740 -745.
7Arai T, Nakano T, Morita S, et al. High dose rate after loading intrac; avitary radiation therapy for cancer of the uterine cervix [ J ]. Cancer, 2003,69(1 ) :175.
